ISTA Pharmaceuticals
Overview[edit | edit source]
ISTA Pharmaceuticals was a pharmaceutical company that specialized in the development and commercialization of therapies for diseases and conditions of the eye. The company was known for its focus on ophthalmology and had a range of products aimed at treating various eye disorders.
History[edit | edit source]
ISTA Pharmaceuticals was founded with the mission to address unmet medical needs in the field of ophthalmology. Over the years, the company developed a portfolio of products that targeted conditions such as glaucoma, dry eye syndrome, and allergic conjunctivitis.
Products[edit | edit source]
ISTA Pharmaceuticals developed several notable products, including:
- Bromday - A nonsteroidal anti-inflammatory drug (NSAID) used to treat postoperative inflammation and reduce pain in patients who have undergone cataract surgery.
- Xibrom - Another NSAID indicated for the treatment of inflammation and pain associated with cataract surgery.
- Vitrase - An enzyme used as a spreading agent to facilitate the dispersion and absorption of other injected drugs.
Acquisition[edit | edit source]
In 2012, ISTA Pharmaceuticals was acquired by Bausch + Lomb, a leading global eye health company. This acquisition allowed Bausch + Lomb to expand its portfolio of ophthalmic pharmaceuticals and enhance its research and development capabilities in the field of eye care.
Research and Development[edit | edit source]
ISTA Pharmaceuticals was committed to innovation in ophthalmology. The company invested in research and development to create new therapies for eye diseases. Their R&D efforts were focused on improving existing treatments and developing new solutions for conditions such as macular degeneration and diabetic retinopathy.
Impact on Ophthalmology[edit | edit source]
The contributions of ISTA Pharmaceuticals to the field of ophthalmology were significant. By providing effective treatments for common eye conditions, the company helped improve the quality of life for many patients. Their focus on eye health and dedication to innovation set a standard in the industry.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
